This is the first in vivo demonstration that MAT.Ang-1, administered after the onset of sub-lethal endotoxemia, reduces LPS-induced macromolecular leak and improves microcirculatory blood flow in sepsis without changing vascular resistance. Here, ANGPT1 is linked to Sepsis.